Back to Journals » OncoTargets and Therapy » Volume 12
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,576 | Dovepress* | 8,270+ | 1,283 | 9,553 | |
PubMed Central* | 2,306 | 657 | 2,963 | ||
Totals | 10,576 | 1,940 | 12,516 | ||
*Since 13 June 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
7 | 0 | 0 | 1 | 2 | 4 |
View citations on PubMed and Google Scholar